Rituximab outperforms other DMARDs for IgG4-related orbital disease

• Posted on: Oct 4 2019
• By: Saratoga Opthalmology
• Leave a response

This systematic review describes the efficacy of conventional and biologic disease-modifying antirheumatic drugs in IgG4-related orbital disease.
Source: AAO

Posted in: Uncategorized